Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis.
about
Signaling dynamics and peroxisomesNuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?Short chain acyl-CoA dehydrogenase deficiency and short-term high-fat diet perturb mitochondrial energy metabolism and transcriptional control of lipid-handling in liverPPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genesPeroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure.MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.Nutritional background changes the hypolipidemic effects of fenofibrate in Nile tilapia (Oreochromis niloticus).Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesisThe role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target.Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells.E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma.Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer.A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
P2860
Q27007465-C2C87CE8-854F-45DA-8B60-D1DF3A81CEAFQ28066233-7E77BE65-EB76-4E1B-AAD5-2E059D0002D3Q28388364-9A65066C-07A9-4990-BC8C-566691CEBEF7Q35568081-DCA54A4B-2D66-475A-94BB-57379E0203EBQ35677612-D711E72E-2D8B-4DD2-811E-B4D798D9BEBEQ37120406-751839C2-2A16-456F-81B3-D7DF8974544AQ37607478-FF2732D5-3D56-40E2-B535-D3E0144A0F05Q37615168-8C6FB36F-F049-42E5-988D-9EDBE7AA4E15Q38209734-8F186D1A-BD17-45D8-ACB8-54E3FFB85AD3Q38235454-D74EE1D6-A6B7-4D9D-A72B-09CD44432B94Q39468345-1184A895-4200-4D6C-AEC5-C9F9C76B62BEQ48038751-4ABFD3FE-7A58-4132-BEDF-A05DEA9DF8FDQ50068821-0C52DE60-5DE6-42EE-A84C-3724602B42FAQ52680868-E4A501A0-7560-415A-95D0-F19E1220169FQ58694534-5F5CE321-8102-43D2-A4D7-BB1F23B11B0E
P2860
Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... rning in hepatocarcinogenesis.
@en
type
label
Peroxisome proliferator-activa ...... rning in hepatocarcinogenesis.
@en
prefLabel
Peroxisome proliferator-activa ...... rning in hepatocarcinogenesis.
@en
P1433
P1476
Peroxisome proliferator-activa ...... rning in hepatocarcinogenesis.
@en
P2093
Janardan K Reddy
Parimal Misra
P356
10.1016/J.BIOCHI.2013.11.011
P577
2013-11-28T00:00:00Z